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Abstract  
Background: Corticotrophin-releasing hormone receptor-1 gene (CRHR1) variants have 
been implicated in mental health. However, little is known of the effects of CRHR1 on long-
term mental health and behavior in presence of environmental stressors. We assess the effects 
of CRHR1 variant (rs17689918)-by-environment interactions on emotionality and behavioral 
traits, including anxiety, depression, aggression and antisocial behaviors. We also determine 
effects of rs17689918-by-environment-by-sex interactions on the above-mentioned outcomes. 
Methods: Genotypic assessments were carried out in 564 children (mean age 10 years, 
52.5% females) from the ongoing longitudinal Estonian Children Personality Behaviour and 
Health Study (ECPBHS). Information on stressful life events and family relationships were 
available at baseline and information on behavioral and mental health outcomes (self- and 
parent-reports) were available at follow-up ages of 18 and 25 years. ANOVAs were used to 
determine associations of two-way CRHR1-by-environment and three-way CRHR1-by-sex-
by-environment interactions on behavioral and mental health outcomes. 
Results: Two-way CRHR1 interaction effects showed associations between low familial 
warmth and hostility in individuals with the GG genotype. Associations of low familial 
warmth with aggression, of higher number of stressful life events with aggression, and of 
stressful live events with anxious-depressive symptoms were noted in male A-allele carriers 
and female GG homozygotes. 
Conclusion: CRHR1-by-familial environment interactions influence both outwardly-directed 
aggression as well as mood and anxiety disorder symptoms in a sex-specific manner. The 
type of environmental stressor can also influence effects of CRHR1 on behavioral and mental 
health outcomes. 
Keywords: Corticotrophin releasing hormone receptor-1 (CRHR1), stress, gene-by-
environment interactions (GxE), mood, aggression, family 
1. Introduction 
The hypothalamic-pituitary-adrenocortical (HPA) axis regulates stress responses. A well-
functioning HPA axis provides resilience to stressful conditions, but some individuals may 
show maladaptations in stress, and consequently develop mental health problems, such as 
depression and aggression (Böhnke et al., 2010; Holsboer, 2000; Nestler et al., 2002; Pariante 
and Miller, 2001). As to how aberrations in the same system, that is the HPA axis, may give 
rise to divergent outcomes of depression and aggression, is a matter of controversy. Reasons 
for this may include the type of stressor, genetic constitution or gender differences. In this 
study, we determine the role of corticotrophin releasing hormone receptor-1 (CRHR1) gene 
variants and their interactions with stressful life events and family relationships in the 
development of anxious-depressed and aggressive behavior problems. 
Actions of the HPA axis are mediated through the corticotrophin-releasing hormone (CRH). 
CRH stimulates the receptors, CRHR1 and CRHR2, in the brain, of which CRHR1 will be 
the focus here as it has implications for mental health (Blomeyer et al., 2008; Liaw et al., 
1996; Liu et al., 2006; Nemeroff et al., 1988; Schmid et al., 2010). CRHR1 is widely 
distributed in the brain, including the hippocampus, striatum, amygdala, as well as the 
anterior pituitary (Inda et al., 2017). The gene encoding CRHR1, on chromosome 17q21.31 
(CRHR1), has been associated with depression (Bradley et al., 2008; da Silva et al., 2016; Liu 
et al., 2007; Wasserman et al., 2009), especially in presence of stressful life events (Heim et 
al., 2009; Tyrka et al., 2009; Ressler et al., 2010). There is some evidence that the CRHR1 
may also be involved in aggression (Chen et al., 2014; De Luca et al., 2010; Merali et al., 
2004; Nemeroff et al., 1988). However, most studies have assessed interactions of CRHR1 
with self-directed aggression (De Luca et al., 2010; Merali et al., 2004; Nemeroff et al., 1988; 
Wasserman et al., 2008) and little information is available on other dimensions of aggression 
such as bullying, and anti-social behaviors. 
The CRHR1 may be particularly susceptible to the effects of a negative environment. 
Enduring Crhr1 expression changes have been noted in the hippocampus and amygdala of 
rodents subjected to early life and peripubertal stress (Veenit et al., 2014). Crhr1 expression, 
especially in the limbic system, is involved in stress responses and underlies the development 
of anxiety-like behavior in rodents (Müller et al., 2003; Preil et al., 2001; Timpl et al., 1998). 
Further, blockade of CRHR1 in rodents affects hippocampal development and these receptors 
mediate the effects of early life stress on spine density, synaptic pruning, and dendritic 
arborisation (Ivy et al., 2010; Liao et al., 2014; Liu et al., 2016). These results suggest that 
CRHR1, in presence of stress, may modulate hippocampal- and amygdala-mediated 
emotional processing and psychopathology (Bremner et al., 2000; Frodl et al., 2002; Ressler, 
2010). 
Past studies have shown that interactions of CRHR1 variants with stress lead to an increased 
risk for poor mental health outcomes. However, these studies do not distinguish between 
types of stress. For example, while stressful life events are more likely to predispose towards 
the development of depressive problems (Power et al., 2013), a lack of maternal or familial 
warmth is more likely to increase risk for aggressive behaviors (Holmes, 2013). Based on this 
knowledge, we hypothesized that the eventual effect of CRHR1 variants on mental health is 
dependent on the type of stressor. Further, sex may play a role in the interactions between 
stress and CRHR1 variants and their outcomes; sex-differences are well-established in stress 
responses (Bale and Epperson, 2015) and sex-specific effects of risk genes are common in 
mental health outcomes (Ngun et al., 2011; Waller et al., 2016). Therefore, using a large 
prospective population-based cohort, we determine interactions of stress type, CRHR1 
variants, and sex, and investigate their effects on behavior and mental health. 
2. Methods 
2.1. Sample 
This study is based on the ongoing longitudinal Estonian Children Personality Behaviour and 
Health Study (ECPBHS), which includes a younger (mean age of 9 years during sample 
recruitment) and an older cohort (mean age of 15 years during sample recruitment). To-date, 
four assessment waves have been completed for both cohorts. The present study uses data 
only from the younger cohort. Recruitment for the younger cohort began in 1998/99 and this 
first assessment wave included 583 participants with a mean age of nine years (55.4% 
females). The second, third and fourth waves were in 2004, 2007, and 2014, and included 483 
(mean age 15, 54.0% females) 457 (mean age 18, 56.0% females), and 441 participants 
(mean age 25, 56.2% females) respectively. The present analysis includes 564 participants 
(52.5% females) for whom valid genotype data are available. Table 1 presents an overview of 
the measures included in this paper from each assessment point. All subjects were of 
European origin. Further details on the cohort are available in previous publications (Harro et 
al., 2001; Tomson et al., 2011). 
The study was approved by the Tartu University Ethics Review Committee on Human 
Research. Subjects provided written informed consent to participate in the study and all 
procedures were carried out in accordance with the Declaration of Helsinki. 
2.2. Genotyping 
Qiagen QIAamp®DNA Blood Midi Kit was used to extract genomic DNA from whole blood 
samples. Genotyping was performed for CRHR1 rs17689918 with the Applied Biosystems 
ViiATM7 Real-Time PCR System. We used the TaqMan®Pre-Designed SNP Genotyping 
Assay and Solis BioDyne5x HOT FIREPol®Probe qPCR Mix Plus (ROX). Of the total 583 
participants in the first wave of the ECPHBS younger cohort, 564 were genotyped. Subjects 
with the A-allele were combined because of the low number of subjects with the AA 
genotype (n=7). This led to a total of 414 participants to be classified as GG and 150 
participants to be classified as AA/AG. 
2.3. Measures 
Table 1 lists measures available for each wave, and which are described below. 
Table 1.  
Number of subjects (by gender; M = males, F = females) with complete data for CRHR1 rs17689919 
and the respective variables included in this study from each wave. 
 
Measures 
Study waves 
9 yrs 15 yrs 18 yrs 25 yrs 
Stressful life events (SLE) -  M=213, F=251 -  -  
Family relations, Warmth -  M=198, F=250 -  -  
ADHD teacher’s report M=219, F=255 M=180, F=208 M=84, F=133 -  
Buss-Perry Aggression 
Questionnaire (BPAQ) 
-  -  -  M=179, F=234 
Affective Neuroscience 
Personality Scale (ANPS-S) 
-  -  -  M=179, F=234 
Illinois Bully Scale (IBS) self-
reports  
-  -  -  M=179, F=234 
Illinois Bully Scale (IBS) peer-
reports 
-  -  -  M=229, F=263 
Life History of Aggression 
(LHA) interview 
-  -  -  M=180, F=233 
Psychiatric M.I.N.I. interview -  -  -  M=182, F=234 
State-Trait Anxiety Inventory 
(STAI) State Anxiety 
-  M=196, F=238 M=188, F=242 M=177, F=232 
State-Trait Anxiety Inventory 
(STAI) Trait Anxiety 
-  -  M=181, F=243 M=176, F=232 
 
2.3.1. Predictors 
(i) Stressful life events (SLE) were assessed at age 15 with participant-reports or parent-
reports on 21-items, which included events such as, parental death, parental divorce or 
separation, absence of both parents, familial unemployment, financial difficulties and 
poverty, poor living conditions, poor health and chronic diseases, serious illness of a family 
member, death of a close relative, trauma, fear of school, bullying at school and humiliation 
at home (Laas et al., 2014). Events were coded dichotomously and total counts across all 
events represented experienced SLEs. Subjects were divided into low and high SLE groups 
by median split. (ii) Familial warmth and maltreatment was assessed at age 15 using the 
child-reported Tartu Family Relationships Scale or TFRS (Kiive et al., 2010; Paaver et al., 
2008). The TFRS was created for the ECPBHS cohort (Cronbach's α between 0.80 and 0.94) 
and measures four dimensions of family functioning: closeness (15 items with responses 
measured to statements such as “Our family is dedicated to each other”, “The marriage of my 
parents is happy”); support (7 items, e.g., “My family supports me”, “Someone in the family 
helps or has helped me to feel important and special”); misprize (10 items, e.g., “I can make 
no decision on my own”, “I am depreciated at home”); and abuse (emotional and physical, 7 
items, e.g., “Were you ever hit by someone in your family or have you experienced physical 
violence in your family?”). All items were assessed on a 4- or 5-point Likert scale. The four 
dimensions – closeness, support, misprize, and abuse – were combined into two higher order 
scales of warmth (Closeness and Support) and maltreatment (Misprize and Abuse). Subjects 
were divided into low and high (warmth and maltreatment) groups by median split. 
2.3.2. Outcomes 
(i) Aggressive and antisocial behaviors were assessed at mean age 25 using the Buss-Perry 
Aggression Questionnaire (BPAQ, Buss and Perry, 1992), the Life History of Aggression 
Interview (LHA, Coccaro et al., 1997), and the Illinois Bully Scale (IBS, Espelage and Holt, 
2001). The Buss-Perry questionnaire comprises 29-items and measures Physical aggression, 
Verbal aggression, Hostility and Anger. The LHA is a 11 item measure of aggression with 
three subscales: Aggression (including temper tantrums, verbal aggression, indirect 
aggression, non-specific fighting, and physical assault against people), 
Consequences/Antisocial behavior (school disciplinary problems, problems with supervisors, 
antisocial behavior not resulting in police involvement, and antisocial behavior involving the 
police); and Self-directed aggression (self-injurious behavior, and suicide attempts). All items 
were rated on a 5-point scale. The Illinois Bully Scale is an 18 item, self-report measure that 
contains three subscales for measuring the frequency of Fighting, Victimization, and Bullying 
behavior. Participants retrospectively rated bullying, victimization and fighting behaviors 
around age 15 for self and classmates on a 5-point Likert scale. For rating classmates, 
participants were first asked to pick the first one or two subjects they remembered well from 
the list of classmates. The list was narrowed gradually, and when raters could not make a 
decision, they were asked to pick someone from the list of already rated subjects. The scores 
were averaged in case of more than one rating per subject. (ii) ADHD symptoms were 
assessed by teachers at ages 9 (n = 493), 15 (n = 402) and 18 (n = 227) as described in Kiive 
et al. (2010) using the 7-point Hyperactivity Scale (af Klinteberg and Oreland, 1995). 
Information was available on Motor restlessness, Concentration difficulties, and 
Aggressiveness. Hyperactivity measures were calculated by summing Concentration 
difficulties and Motor restlessness scores. (iii) Anxious-depressive symptoms were assessed as 
follows. Symptoms of anxiety were assessed at ages 15 (only State anxiety, n = 449), 18 
(nState = 445, nTrait = 439) and 25 (nState = 423, nTrait = 422) with the Spielberger State Trait 
Anxiety Inventory (STAI, Spielberger, 1983). Depressive symptoms were assessed with self-
reports on the Montgomery-Åsberg Depression Rating Scale (MÅDRS; Montgomery and 
Åsberg, 1979) at age 18 (n = 421) and 25 (n = 425). Further, lifetime presence of mood 
disorders at age 25 was determined with the Mini-International Neuropsychiatric Interview 
(M.I.N.I.5.0.0; Shehan et al., 1998) and according to DSM-IV criteria by experienced 
psychologists. (iv) Behavioral traits were assessed at age 25 with the short version of the 
Affective Neuroscience Personality Scales (ANPS-S; Pingault et al., 2012). The ANPS-S is 
used to measure participants' behavioral traits on 6 affective - systems (Play, Seek, Care, 
Fear, Anger, and Sadness). 
2.4. Analyses 
Fisher's exact test was used to determine genotype distributions between psychiatric 
disorders. Analysis of variance (ANOVA) was used to determine group differences in 
aggressive, impulsive and anxiousdepressive outcomes. First, differences between CRHR1 
genotypes were assessed. Next, interactions of genotype with stress and sex were included to 
assess if type of stress and sex influenced effects of genotype on adolescent and young adult 
outcomes. For all interactions that were significant, additional post-hoc tests were carried out 
to assess specific group differences. 
3. Results 
We found no effects of CRHR1 genotype or CRHR1-by-sex interactions on adolescent or 
young adult outcomes. However, two-way CRHR1-by-environment interactions and three-
way CRHR1-by-sex-byenvironment interactions were associated with a number of outcomes 
and are reported below.  
3.1. Aggression and antisocial behaviors 
CRHR1-by-family warmth interaction showed a significant association with Buss Perry 
subscales of Anger (F(1, 354) = 4.56, p = 0.033, ƞ2 = 0.013) and Hostility (F(1, 354) = 6.63, p = 
0.011, ƞ2 = 0.018). Low family warmth was associated with Anger and Hostility in 
participants with the GG genotype (Fig. 1A). We found no effects on outcomes of Physical or 
Verbal aggression. Further, no associations were found between CRHR1-by-SLE interaction 
and outcomes assessed with the Buss-Perry questionnaire. 
We found no effects of two-way or three-way CRHR1 interactions on risk for peer-reported 
Aggression or Victimization, assessed with the Illinois Bully Scale. However, in an 
exploratory analysis, we found an effect of CRHR1-by-SLE interaction on risk for peer-
nominated Victimization in males only (F(1, 182) = 5.32, p = 0.022, η2 = 0.028). Similar to 
results from aggressive outcomes, the higher risk for victimization with SLEs was found in 
males carrying the A-allele (Fig. 1B). 
 
 
 
 
 
 
 
 
 
 
Fig. 1. CRHR1 effects by environment or by environment and Sex on Buss-Perry Aggression 
Questionnaire (BPAQ) Hostility and Anger (A); Illinois Bully Scale (IBS) peer-reported 
Victimization (B); and on Life History of Aggression interview (LHA) Aggression and the Total 
scores. # - p = 0.068; * - p < 0.05, ** - p < 0.01, *** < 0.001 - differences between indicated groups. 
Whiskers indicate 95% confidence intervals. 
 
 
We found effects of CRHR1-by-sex-by-family warmth interactions on the LHA Aggression 
subscale (F(1, 347) = 4.97, p = 0.026, η2 = 0.014) and LHA total scores (F(1, 347) = 5.76, p = 
0.017, η2 = 0.016). Results from post-hoc tests showed that low family warmth was 
associated with higher aggression in males carrying the A-allele and females with the GG 
genotype (Fig. 1C). We also found an association between CRHR1-by-sex-by-SLE 
interaction and scores on the Aggression subscale of the LHA (F(1, 356) = 4.30, p = 0.039, η2 = 
0.012). Post-hoc testing showed that high stress was associated with greater aggression scores 
in males with the A-allele and females with the GG genotype. 
3.2. ADHD 
We found no effects of CRHR1-by-environment interactions on ADHD symptoms. However, 
CRHR1-by-sex-by-family maltreatment (F(1, 189) = 7.20, p = 0.008, ƞ2 = 0.037) and CRHR1-
by-sex-by-SLE (F(1, 200) = 4.19, p = 0.042, ƞ2 = 0.021) were associated with Aggressiveness 
symptoms at age 18 as assessed with the af Klinteberg 7-point hyperactivity scale. Post-hoc 
tests showed higher aggression in A-allele males and GG females with higher maltreatment 
or SLEs (Fig. 2). Further, we found associations between CRHR1-by-sex-by-family 
maltreatment interaction and motor restlessness at age 18 years (F(1,189) = 7.34, p = 0.007, ƞ2 
= 0.037). We found no genotype-related effects on Concentration difficulties at any age.  
Fig. 2. CRHR1 × Sex × environment effects on af Klinteberg hyperactivity scale Aggressivity: G × 
Sex × Maltreatment (A) and G × Sex × SLE (B). * - p < 0.05, ** - p < 0.01 - differences between 
indicated groups. Whiskers indicate 95% confidence intervals. 
 
3.3. Anxious and depressive symptomatology 
We found an association of the CRHR1-by-sex-by-SLE interaction with depressive scores at 
age 18 (F(1, 348) = 5.10, p = 0.024, η2 = 0.014), but not age 25 as per the MADRS reports. A-
allele males and GG females with higher SLEs reported greater depressiveness (Fig. 3A). 
Fig. 3. CRHR1 × Sex × SLE effects on MÅDRS depressiveness (A) and STAI State anxiety (B). * - p 
< 0.05, ** - p < 0.01, *** < 0.001 - differences between indicated groups. Whiskers indicate 95% 
confidence intervals. 
 
 
CRHR1-by-sex-by-SLE interactions were significantly associated with State, but not Trait, 
anxiety as assessed by STAI, at ages 18 (F(1,362) = 3.98, p = 0.047, η2 = 0.011) and 25 (F(1, 352) 
= 4.59, p = 0.033, η2 = 0.013). Males with the A-allele and higher SLE showed higher State 
anxiety scores at both age 18 and age 25 (Fig. 3B). No effects on State anxiety were found in 
females. 
CRHR1-by-sex-by-SLE interactions were associated with the prevalence of mood disorders 
assessed by the MINI in males (in low SLE group p=0.039, in high p = 0.442). Low SLE was 
associated with a lower risk for depression in males with the GG genotype (Fig. 4). No 
effects on mood disorders were found in females (p(in low SLE group) = 0.625, p(in high) = 0.598). 
 
Fig. 4. CRHR1 × SLE effect on the prevalence 
of mood disorders assessed by MINI in males:  
Males with the GG genotype had the lowest 
odds (OR = 0.25 (0.07; 0.87) for developing a 
mood disorder in the low-SLE group.  
 
 
3.4. Behavioral traits 
No associations were found between CRHR1-by-environment interactions and behavioral 
traits as per the ANPS-S. Results showed an effect of CRHR1-by-sex-by-SLE interaction on 
Seeking subscale (F(1, 356) = 5.08, p = 0.025, η2 = 0.014). Post-hoc testing showed that males 
with the A-allele and higher number of stressful life events had the lowest Seeking scores 
(Fig. 5). 
 
 
 
Fig. 5. CRHR1 × Sex × SLE effect on ANPS-S 
subscale SEEK. * - p < 0.05 - differences 
between indicated groups. Whiskers indicate 
95% confidence intervals. 
4. Discussion 
Using a large population-based cohort, we aimed to understand the effects of CRHR1 
rs17689918 and its interaction with SLE, family maltreatment, and family warmth on mental 
health and behavioural outcomes in late adolescence and young adulthood. Further, we aimed 
to assess if the effects of CRHR1 differed by type of environment (high SLE, high family 
maltreatment, or low familial warmth) and sex. In general, our results support a higher 
susceptibility for poor outcomes in males carrying the A-allele and females with the GG 
variant given an early negative environment. We also found evidence to suggest that the type 
of environmental stressor may influence the effects of CRHR1 variants on adolescent and 
adult outcomes. 
Previous studies on CRHR1 have mainly focussed on its role in depressive outcomes and 
fewer studies have assessed effects on self-directed aggression. Here, we additionally 
demonstrate an effect of CRHR1 on the risk for outwardly-directed aggression, including 
anger and hostility. The interaction of stress (in adolescence) with CRHR1 is associated with 
prospective aggressive outcomes. As hypothesized we found an effect of sex where males 
with the A-allele showed a greater predisposition for aggressive behaviour outcomes. In 
contrast, risk for aggression was higher in females with the GG genotype, but not A-allele, in 
presence of a negative environment. 
In two previous studies, the rs110402 A-allele was shown to have a protective effect against 
major depressive disorder in both males and females exposed to childhood abuse (Bradley et 
al., 2008; Polanczyk et al., 2009). In our study, the risk for depressive problems was higher in 
males with the rs17689918 A-allele, and in females with the GG variant. The risk for poor 
anxiety outcomes in presence of early stress was seen exclusively in males with the A-allele. 
Taken together with our results on aggressive outcomes, this suggests varied effects of 
CRHR1 variants in the two sexes. 
The effects of CRHR1 on ADHD and peer problems were less clear. We found some 
evidence to suggest that CRHR1 interacts with early stress interactions to influence motor 
restlessness and susceptibility to victimization. However, we did not find any associations of 
CRHR1 with concentration difficulties, bullying or antisocial behaviors. The lack of effects 
on bullying and anti-social behaviors is surprising given that we found clear effects of 
CRHR1 on anger, (LHA) aggression, and hostility. Moreover, as noted in a previous paper 
from the ECPBHS, these aggressiveness measures – bullying, anti-social behaviors, anger, 
hostility and LHA aggression – are correlated (Kiive et al., 2017). Further, in Kiive et al. 
(2017), all aggressiveness measures were associated with GABRA2 (Gamma-aminobutyric 
acid receptor 2) genotype. This suggests that the GABA-A receptor may be more generally 
associated with aggressiveness than the CRH receptor. 
It is possible that CRHR1 affects selective dimensions of aggression. For example, 
differential effects on callous unemotional traits, proactive or reactive aggression, may partly 
explain the variance in effects on aggression versus antisocial behaviors. It is known that 
aggressive behaviors in mood disorders are associated with increased HPA axis activity and 
hypercortisolism (Veenema, 2009). This form of aggression may be reactive or impulsive 
which is a defensive response to provocation, and which differs from the proactive or 
premediated aggression common in conduct and personality disorders (Kempes et al., 2005). 
HPA responses also differ in conduct/personality disorder-associated aggression, showing 
low HPA axis activity and hypocortisolism (Veenema, 2009). Given that the CRHR1 
rs17689918 was associated with both mood problems and aggression in our sample, we can 
speculate that an associated increase in HPA axis functioning and hypercortisolism may 
underlie the behavioral outcomes reported. That is, aggression mediated by the CRHR1 could 
be of the reactive or impulsive type. Notably, CRH and CRHR1 variants have been reported 
to moderate fear conditioning responses, in turn leading to heightened anxiety (Bijlsma et al., 
2011; Heitland et al., 2016; Roozendaal et al., 2002; Thoeringer et al., 2012). Since 
aggression in response to fear conditioning is likely to be reactive, CRHR1 may too mediate 
reactive, but not proactive aggression (Veenema, 2009; Vitiello and Stoff, 1997). 
Dissecting the role of CRHR1 is important for understanding aggressive comorbidity, which 
is common in depression, suicidal ideation, post-traumatic stress disorder, and substance 
abuse. These disorders are associated with neural structure and functioning problems in the 
amygdala and the hippocampus; regions that express CRHR1 and are susceptible to CRHR1 
modulation in response to stress (Inda et al., 2017; Seo et al., 2008; Veenit et al., 2014). Thus 
CRHR1 expression and CRHR1 function may present a pathway to the development of 
aggressive comorbidity. Further, the association of aggression and fear conditioned responses 
may be dependent on CRHR1, perhaps via alteration of amygdala function (Herry and 
Johansen, 2014). It is already well known that CRH signaling within the hippocampus and 
amygdala influence fear acquisition and consolidation of fear memories (Kolber et al., 2008; 
Roozendaal et al., 2002). Recent studies also demonstrate the association of CRHR1 
polymorphisms with fear responses. For example, the rs878886 has been associated with 
reduced fear conditioning responses (Heitland et al., 2013; Heitland et al., 2016). The CRHR1 
rs17689918, meanwhile, has been associated with fear sensitization and anxious symptoms in 
fear provocation (Weber et al., 2016). Therefore, further study of CRHR1 variants and their 
modulation of fear responses can provide an operational genetic mechanism that explains fear 
conditioning and aggressive behavior. 
Our results show that CRHR1-by-stress interactions predicted lower reward and sensation 
seeking behavior, exclusively in males with the Aallele. Lower sensation seeking is linked to 
a higher risk for depression (Panksepp and Watt, 2011). Thus, the effects of CRHR1 on 
depressive outcomes could be mediated by low seeking behaviors, at least in males. This 
proposition, if confirmed by future studies, would further support a differential effect of 
CRHR1 variants by gender. 
There was some evidence to suggest that the type of environmental stress may affect eventual 
outcome. We hypothesized that low family warmth or high mistreatment in our sample would 
likely affect aggressive outcomes, while high SLEs would influence the risk for depression. 
In line with this, our results showed that the risk for mood problems and victimization was 
predicted only by interactions of CRHR1-by-SLE, and not by interactions of familial warmth 
with CRHR1. However, both low family warmth and high SLEs were associated with 
aggressive outcomes. It should be noted though that family warmth was associated with 
specific dimensions of aggression, such as anger and hostility, while SLEs were more likely 
to be associated with generalized measures of aggressive outcomes. 
A few limitations to this study warrant attention. First, we did not control for multiple testing 
which may bias our findings. It has though been noted that the application of a correction for 
multiple testing may create “more problems than it solves” (Perneger, 1998; Moran, 2003; 
Nakagawa 2004). Second, stress was assessed in adolescence, but not in childhood. It could 
be argued that early childhood stress would have a greater effect on mental health. However, 
cognitive maturation continues well beyond adolescence into early adulthood and any stress 
during this time could potentially impair mental health outcomes. Thus, our study highlights 
the effects of such adolescent-onset stress on outcomes. Future research may address effects 
of childhood and adolescent stress on mental health and further determine if time-dependent 
effects of stress may explain the widespread effects of CRHR1 on mental health. Third, 
depressed-anxious symptoms and aggressive, antisocial behaviors were not assessed at 
baseline. Thus, these variables could not be controlled for in our analyses, and the possibility 
of baseline symptomatology affecting future outcomes cannot be ruled out.  
In conclusion, CRHR1 variants interact with early stress experience and influence long-term 
mental health and behavior. Using a longitudinal population-representative cohort, we report 
that type of stress and sex may moderate the influence of CRHR1 variation on risk for 
aggressive, anxious, and mood symptoms as well as behavioral traits. Future research should 
be directed at understanding the developmental effects of CRHR1-by-stress interactions. This 
knowledge has the potential to address developmental trajectory changes subject to HPA 
system fine-tuning by environmental factors and the effects of such changes on mental health 
outcomes. 
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